EUVIMED · CrossrefZeitschrift
Expert Opinion on Biological Therapy
ISSN 1471-2598 · Informa UK Limited
Neueste Artikel
Cosibelimab for advanced cutaneous squamous cell carcinoma: pharmacological rationale and clinical evidence
Pharmacological treatment of hematopoietic stem cell transplantation-associated thrombotic microangiopathy with focus on the FDA-approved antibody narsoplimab
The double-edged sword: a contemporary perspective on biologics for anti-cytokine syndromes
Three decades of PRPs: keeping the flame alive for blood as a source of repair and regeneration
Effectiveness of switching from reference adalimumab to biosimilar adalimumab-atto in patients with chronic non-infectious uveitis
An evaluation of sacituzumab tirumotecan for the treatment of NSCLC
RNA-targeting therapeutics for rare neuromuscular diseases: progress, challenges, and the path toward personalized treatment
Redefining breast cancer treatment by precision oncology: the clinical impact of sacituzumab govitecan
Subcutaneous infliximab in inflammatory bowel disease: from pharmacokinetic principles to clinical practice
Navigating TNF and il‑17 pathways in hidradenitis suppurativa: real‑world lessons and future biologic combinations
The cost of delay: foregone public expenditure savings from delayed adalimumab biosimilar listing in Australia’s Pharmaceutical Benefits Scheme
Changes in the FIB-4 index with IL-23 vs IL-17 inhibitors in psoriasis: a retrospective cohort study
Emerging therapeutic strategies and clinical trials in severe asthma management: current evidence and future directions
Current and emerging sublingual immunotherapies for dust mite allergy
Biologics in alopecia areata: promise, paradox, and the precision medicine frontier
An evaluation of marnetegragene autotemcel for the treatment of severe leukocyte adhesion deficiency type I
Innovative positioning of respiratory allergen immunotherapy: a focus on precision medicine
Threats to validity of the PESTO perispinal etanercept stroke trial: a document-based clinical trial evaluation
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis
Correction
Developability-by-design for bispecific antibodies in discovery: combining computational prediction and early screening for candidate selection
Progress in gene therapy for RPGR-associated X-linked retinitis pigmentosa
Assessing the effectiveness of biologics in biologic-naïve patients with isolated small bowel Crohn’s disease by double-balloon endoscopy
An evaluation of denecimig for bleeding prophylaxis in hemophilia A
Real-world effectiveness and drug retention rate of risankizumab in patients with psoriatic arthritis: data from the multicentre GIRRCS cohort
Dopamine-replacing gene therapy for Parkinson’s disease: biochemical background and current clinical experience
Biologic therapies for adult chronic urticaria: what works, what doesn’t, and why
Harnessing novel agents to target KRAS-driven pathways in pancreatic cancer
In vivo CAR T cells on the highway: a roadmap for the next decade
Patient-centered approaches in psoriasis management: lessons from the past and future directions
EUVIMED